Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

The Medicines Company Company Profile (NASDAQ:MDCO)

Consensus Ratings for The Medicines Company (NASDAQ:MDCO) (?)
Ratings Breakdown: 4 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $31.69 (16.97% upside)

Current Analysts' Coverage Summary for The Medicines Company (NASDAQ:MDCO)
Show:
DateFirmActionRatingPrice TargetActions
5/9/2015RBC CapitalReiterated RatingOutperform$38.00 -> $39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015JPMorgan Chase & Co.Boost Price TargetOverweight$31.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015ZacksDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Leerink SwannLower Price TargetOutperform$35.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015Citigroup Inc.Set Price TargetHold$30.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/10/2015MizuhoLower Price TargetNeutral$30.00 -> $27.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2014Credit SuisseUpgradeNeutral -> Outperform$27.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2014Bank of AmericaLower Price TargetBuy -> Neutral$37.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/2/2014Piper JaffrayDowngradeOverweight -> Neutral$41.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2014TheStreetDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/13/2014Jefferies GroupDowngradeBuy -> Hold$38.50 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2013OppenheimerInitiated CoverageOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/25/2013 forward)